14c = 340) was first brominated with CuBr 2 to give the 16a-bromo derivative 2 which was then oxidized with 8 N Cr03 and subsequently treated with p-toluenesulfonic acid, yielding the 4-ene-3-keto derivative 3. [3H,14C]Compound 3 was hydrolyzed with 1.2 eq of NaOH in aqueous pyridine to give 3H-and 14C-labeled compound 4 (21% from compound 1; specific activity, 3H 3.20 mCi/mmol; 3H/14C = 222, this ratio is equivalent to a 35% loss of the tritium from DHEA which could be attributed to the C-2 position). The labeled 16a-ketol 4 was identical with authentic non-labeled compound, and its radiochemical purity was established to be more than 98% by thin-layer chromatography (TLC) and reverse isotope dilution analysis (Table I) . The distribution of tritium in the double labeled 16a-ketol 4 was initially determined by chemical and biochemical methods. After incubation of 4 with human placental microsomes [l,2-3H, "C] 1 6I-Hydroxyandrostenedione (9. 1 pm) was incubated with the placental microsomes (1.1 mg protein/ml) in the presence of NADPH over various time periods. The 3H20 formation was determined as described in the text. 42, 3299 (1982) .
3) The trivial names used are: androstenedione, 4-androstene-3,17-dione; 16a-hydroxyandrostenedione, 16a-hydroxy-4-androstene-3,17-dione; dehydroepiandrosterone (DHEA), 3ƒÀ-hydroxy-5-androsten-17-one; estriol,
